About | Free Trial

Last Update

2016-07-18T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Victor Shi?

Dr. Victor Shi

President, Asia Pacific

QIAGEN N.V.

Direct Phone: +86 **********       

QIAGEN N.V.

Hulsterweg 82

Venlo, 5912 PL

Netherlands

Company Description

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from b... more

Find other employees at this company (3,709)

Background Information

Employment History

Cancer Research Scientist

Merck & Co. , Inc.

Affiliations

Deputy Secretary-General
Chinese In-Vitro Diagnostics Industry Association

Board Member
Sponsorship Committee

Faculty Member
National University of Singapore School of Medicine

Founding Board Member
BayHelix

Faculty Member
National University of Singapore

Founder
DRS

Education

Bachelor's degree

University of Science and Technology of China

M.S. Degree

University of Rochester School of Medicine , New York

M.S. degrees

University of Rochester , New York

Ph.D.

Ph.D.

University of Rochester , New York

Ph.D. degree

University of Rochester School of Medicine , New York

Web References (100 Total References)


BioBay Investor Forum 2010 - Speaker Bios

www.chinabiollc.com [cached]

Victor Shi, PhD - President, Asia Pacific, QIAGEN

Dr. Victor Shi is Asia Pacific President of QIAGEN, a publicly-listed world leading provider of sample and assay technologies in the field of molecular diagnostics. Dr. Shi heads QIAGEN's commercial operations and strategic development in Asia and manages an organization with over 500 employees in 11 subsidiaries. Dr. Shi has over 17 years' experience in life science business development, management and investment. Previously held positions include Managing Partner, Aura Partners (Shanghai and Hong Kong), Senior Vice President of Corporate Development, Bridge Pharmaceuticals (Menlo Park, California), Managing Director of Discovery Resources Group (Palo Alto, California), Vice President of Corporate Development at Genospectra (Fremont, California), and Director of Asia Operations at A. M. Pappas & Associates (Singapore). He was also a faculty member at National University of Singapore School of Medicine and a cancer research scientist at Merck & Co. Dr. Shi holds PhD and MS degrees from the University of Rochester, New York, and a B.S. degree from the University of Science and Technology of China.


BioBay Investor Forum 2011 - Speaker Bios

www.chinabiollc.com [cached]

Victor Shi, PhD - President, Asia Pacific, QIAGEN

Dr. Victor Shi is Asia Pacific President of QIAGEN, a publicly-listed world leading provider of sample and assay technologies in the field of molecular diagnostics. Dr. Shi heads QIAGEN's commercial operations and strategic development in Asia and manages an organization with over 500 employees in 11 subsidiaries. Dr. Shi has over 17 years' experience in life science business development, management and investment. Previously held positions include Managing Partner, Aura Partners (Shanghai and Hong Kong), Senior Vice President of Corporate Development, Bridge Pharmaceuticals (Menlo Park, California), Managing Director of Discovery Resources Group (Palo Alto, California), Vice President of Corporate Development at Genospectra (Fremont, California), and Director of Asia Operations at A. M. Pappas & Associates (Singapore). He was also a faculty member at National University of Singapore School of Medicine and a cancer research scientist at Merck & Co. Dr. Shi holds PhD and MS degrees from the University of Rochester, New York, and a B.S. degree from the University of Science and Technology of China.


"The launch of careHPV in ...

www.strategic-directions.com [cached]

"The launch of careHPV in India will help in efforts to reduce the high burden of cervical cancer for women in India," said Dr. Victor Shi, President of QIAGEN Asia Pacific.


"Qiagen and KingMed ...

www.genengnews.com [cached]

"Qiagen and KingMed Diagnostics have had a long and fruitful collaboration that we are significantly expanding," comments Victor Shi, M.D., Qiagen's Asia Pacific president.


Victor Shi Aisa ...

events.cbichina.com [cached]

Victor Shi Aisa Pacific President Qiagen

...
Dr. Victor Shi is Asia Pacific President of QIAGEN, a publicly-listed world leading provider of sample and assay technologies in the field of molecular diagnostics. Dr. Shi heads QIAGEN's commercial operations and strategic development in Asia and manages an organization with over 500 employees in 11 subsidiaries.
Dr. Shi has over 17 years' experience in life science business development, management and investment. Previously held positions include Managing Partner, Aura Partners (Shanghai and Hong Kong), Senior Vice President of Corporate Development, Bridge Pharmaceuticals (Menlo Park, California), Managing Director of Discovery Resources Group (Palo Alto, California), Vice President of Corporate Development at Genospectra (Fremont, California), and Director of Asia Operations at A. M. Pappas & Associates (Singapore). He was also a faculty member at National University of Singapore School of Medicine and a cancer research scientist at Merck & Co. Dr. Shi holds Ph.D. and M.S. degrees from the University of Rochester, New York, and a B.S. degree from the University of Science and Technology of China.

Similar Profiles

Other People with this Name

Other people with the name Shi

Wenbo Shi
Harvard Center for Green Buildings and Cities

Lilian Shi
Bree Lighting Co. , Limited

Selina Shi
Valsfer

Lei Shi

Charlie Shi
South China Normal University

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory